Skip to main content
The AAPS Journal logoLink to The AAPS Journal
. 2005 Sep 2;7(1):E241–E248. doi: 10.1208/aapsj070123

Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic

Wenzhan Yang 1, Melgardt M de Villiers 1,
PMCID: PMC2751513  PMID: 16146345

Abstract

The present study investigated the effect of water-soluble 4-sulphonato-calx[n]arenes, cyclodextrins, and combinations of these macromolecules on the aqueous solubility of a poorly water-soluble drug, niclosamide. Complexation between the macromolecules and niclosamide was confirmed by thermal analysis and phase solubility studies in a pH 7.0 McIlvaine buffer kept at 30°C. Results show that the increase in solubility ranked as follows: 4-sulphonato-calix [6]arene+hydroxypropyl-β-cyclodextrin (HP-β-CD)> 4-sulphonato-calix[6]arene+β-cyclodextrin > 4-sulphonato-calix[6]arene +γ-cyclodextrin=HP-β-CD>4-sulphonato-calix[6]arene >4-sulphonato-calix[8]arene=4-sulphonato-calix[4]arene>β-cyclodextrin. Type B phase solubility profiles were observed, indicating a decrease in solubility at concentrations > 0.004 to 0.005 mol/L of the 4-sulphonato-calix[n]arenes or combinations of 4-sulphonato-calix[6]arene and the cyclodextrins. However, below this concentration, the greatest increase in the aqueous solubility niclosamide was observed when 4-sulphonato-calix[6]arene and HP-β-CD were combined. This increase in solubility was additive.

Keywords: niclosamide, solubilization, 4-sulphonatocalix[n]arenas, cyclodextrins

Full Text

The Full Text of this article is available as a PDF (398.2 KB).

References

  • 1.Reynolds JEF, editor. Martindale:The Extra Pharmacopoeia. 29th ed. London: The Pharmaceutical Press; 1989. pp. 987–991. [Google Scholar]
  • 2.Goldsmith RS. Clinical pharmacology of anthelminitic drugs. In: Katzung BG, editor. Basic and Clinical Pharmacology. Los Angeles: Lange Medical; 1984. pp. 659–660. [Google Scholar]
  • 3.The Merek Index, 13th ed. Rahway, NY: Merck; 2001.
  • 4.Szejtli J. Cyclodextrin Technology. Boston: Kluwer Academic Publishers; 1988. [Google Scholar]
  • 5.Gutsche D. Calixarenes. In: Vögtle F, Weber E, editors. Host Guest Complex Chemistry Macrocycles, Synthesis, Structures, Applications. Tokyo: Springer; 1985. [Google Scholar]
  • 6.Gutsche CD. The characterization and properties of calixarenes. In: Stoddart JF, editor. Calixarenes, Monographs in Supramolecular Chemistry No. 1. Cambridge: The Royal Society of Chemistry; 1989. [Google Scholar]
  • 7.Shuette JM, Ndou TT, Warner IM. Cyclodextrin-induced asymmetry of a chiral nitrogen heterocycles. J Phys Chem. 1992;96:5309–5314. doi: 10.1021/j100192a025. [DOI] [Google Scholar]
  • 8.Silva E, Shahgaldian P, Coleman AW. Háemolytic properties of some water-soluble para-sulphonato-calix-[n]-arenes. Int J Pharm. 2004;273:57–62. doi: 10.1016/j.ijpharm.2003.12.008. [DOI] [PubMed] [Google Scholar]
  • 9.Silva E, Lazar AN, Coleman AW. Biopharmaceutical applications of calixarenes. J Drug Del Sci Tech. 2004;14:3–20. [Google Scholar]
  • 10.Szejtli J. Cyclodextrins and Their Inclusion Complexes. Budapest: Akademiai Kiado; 1982. [Google Scholar]
  • 11.Millership JS. A preliminary investigation of the solution complexation of 4-sulphonic calix[n] arenes with testosterone. J Incl Phenom. 2001;39:327–331. doi: 10.1023/A:1011196217714. [DOI] [Google Scholar]
  • 12.Silva E, Valmalle C, Becchi M, Cuilleron CY, Coleman AW. The use of electrospray mass spectrometry (ES/MS) for the differential detection of some steroids as calix[n]arene sulphonate complexes. J Incl Phenom Macro Chem. 2003;46:65–69. doi: 10.1023/A:1025685628493. [DOI] [Google Scholar]
  • 13.Yang W, Villiers MM. The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[n]arenes. Eur J Pharm Biopharm. 2004;58:629–636. doi: 10.1016/j.ejpb.2004.04.010. [DOI] [PubMed] [Google Scholar]
  • 14.Yang W, Villiers MM. Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes. J Pharm Pharmacol. 2004;56:703–708. doi: 10.1211/0022357023439. [DOI] [PubMed] [Google Scholar]
  • 15.Liu Y, Han B, Chen Y. Molecular recognition and complexation thermodynamics of dye guest molecules by modified cyclodextrins and calixarenesulphonates. J Phys Chem B. 2002;106:4678–4687. doi: 10.1021/jp015603r. [DOI] [Google Scholar]
  • 16.Castro R, Godinez L, Criss C, Kaifer AE. Host properties of α-cyclodextrin and a water-soluble calix[6]arene probed with dimetric bipyridinium guests. J Org Chem. 1997;62:4928–4935. doi: 10.1021/jo9701997. [DOI] [Google Scholar]
  • 17.Higuchi T, Conners KA. Phase-solubility techniques. In: Reilly CN, editor. Advances in analytical chemistry and instrumentation. New York: John Wiley; 1965. pp. 117–212. [Google Scholar]
  • 18.ICH-Q2A.Text on Validation of Analytical Procedures. Geneva: ICH Secretariat, 1995.
  • 19.Rogers TL, Nelsen AC, Hu J, et al. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur J Pharm Biopharm. 2002;54:271–280. doi: 10.1016/S0939-6411(02)00063-2. [DOI] [PubMed] [Google Scholar]
  • 20.Boje KM, Sak M, Fung HL. Complexation of inifedipine with substituted phenolic ligands. Pharm Res. 1998;5:655–659. doi: 10.1023/A:1015979021590. [DOI] [PubMed] [Google Scholar]
  • 21.Gutsche CD. Complex formation with calixarenes. In: Stoddart JF, editor. Calixarenes Revisited. Hertfordshire: The Royal Society of Chemistry; 1998. [Google Scholar]
  • 22.Shinkai S, Araki K, Manabe O. Does the calixarene cavity recognize the size of guest molecules? On the ‘hole-size selectivity’ in water-soluble calixarenes. J Chem Soc Chem Commun. 1988;3:187–189. doi: 10.1039/c39880000187. [DOI] [Google Scholar]
  • 23.Vicens J, Böhmer V. Calixarenes: A Versatile Class of Macrocyclic Compounds. Dordrecht: Kluwer Academic Publishers; 1991. [Google Scholar]

Articles from The AAPS Journal are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES